Loading...
Aliskiren and the dual complement inhibition concept
In this issue of Clinical Kidney Journal, Plasse et al. report on the use of high-dose aliskiren as an adjunct therapy in a patient treated with eculizumab for haemolytic uraemic syndrome (HUS). This follows the recent description of the complement factor 3 (C3) activating activity of the enzyme ren...
Na minha lista:
| Udgivet i: | Clin Kidney J |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7025362/ https://ncbi.nlm.nih.gov/pubmed/32083617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfz142 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|